Proportions of studied patients with respective cancer types among people living with HIV who had any malignancies (n=117)
| Patients with malignancy (n=117) | |
| n (%) | |
| AIDS-defining cancer | |
| Non-Hodgkin’s lymphoma | 61 (52.1) |
| Kaposi sarcoma | 16 (13.7) |
| Burkitt lymphoma | 5 (4.3) |
| Cervix uteri | 2 (1.7) |
| Non-AIDS-defining cancer | |
| Bronchus or lung | 8 (6.8) |
| Secondary malignant neoplasm of bone and bone marrow | 6 (5.1) |
| Colon | 3 (2.6) |
| Breast | 3 (2.6) |
| Malignant neoplasm, without specification of site | 3 (2.6) |
| Secondary malignant neoplasm of brain and cerebral meninges | 3 (2.6) |
| Acute myeloblastic leukaemia | 3 (2.6) |
| Multiple myeloma | 3 (2.6) |
| Stomach | 2 (1.7) |
| Secondary malignant neoplasm of lung | 2 (1.7) |
| Liver cell carcinoma | 2 (1.7) |
| Sigmoid colon | 2 (1.7) |
| Thoracic part of oesophagus | 2 (1.7) |
| Skin of trunk | 2 (1.7) |
| Others* | 23 (19.7) |
*Non-AIDS-defining cancer types present only in one patient were grouped and presented as ‘others’.